Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Rifampicin Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Oral
  • 1.3.3 Intravenous Injection
• 1.4 Market Segment by Application
  • 1.4.1 Global Rifampicin Market Share by Application (2019-2025)
  • 1.4.2 Tuberculosis
  • 1.4.3 Leprosy
  • 1.4.4 Legionnaire's Disease
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Rifampicin Market Size
  • 2.1.1 Global Rifampicin Revenue 2014-2025
  • 2.1.2 Global Rifampicin Sales 2014-2025
• 2.2 Rifampicin Growth Rate by Regions
  • 2.2.1 Global Rifampicin Sales by Regions 2014-2019
  • 2.2.2 Global Rifampicin Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Rifampicin Sales by Manufacturers
  • 3.1.1 Rifampicin Sales by Manufacturers 2014-2019
  • 3.1.2 Rifampicin Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Rifampicin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Rifampicin Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Rifampicin Market Concentration Ratio (CR5 and HHI)
• 3.3 Rifampicin Price by Manufacturers
• 3.4 Key Manufacturers Rifampicin Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Rifampicin Market
• 3.6 Key Manufacturers Rifampicin Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Oral Sales and Revenue (2014-2019)
  • 4.1.2 Intravenous Injection Sales and Revenue (2014-2019)
• 4.2 Global Rifampicin Sales Market Share by Type
• 4.3 Global Rifampicin Revenue Market Share by Type
• 4.4 Rifampicin Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Rifampicin Sales by Application

6 United States

• 6.1 United States Rifampicin Breakdown Data by Company
• 6.2 United States Rifampicin Breakdown Data by Type
• 6.3 United States Rifampicin Breakdown Data by Application

7 European Union

• 7.1 European Union Rifampicin Breakdown Data by Company
• 7.2 European Union Rifampicin Breakdown Data by Type
• 7.3 European Union Rifampicin Breakdown Data by Application

8 China

• 8.1 China Rifampicin Breakdown Data by Company
• 8.2 China Rifampicin Breakdown Data by Type
• 8.3 China Rifampicin Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Rifampicin Breakdown Data by Company
• 9.2 Rest of World Rifampicin Breakdown Data by Type
• 9.3 Rest of World Rifampicin Breakdown Data by Application
• 9.4 Rest of World Rifampicin Breakdown Data by Countries
  • 9.4.1 Rest of World Rifampicin Sales by Countries
  • 9.4.2 Rest of World Rifampicin Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Sanofi
  • 10.1.1 Sanofi Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Rifampicin
  • 10.1.4 Rifampicin Product Introduction
  • 10.1.5 Sanofi Recent Development
• 10.2 Wellona Pharma
  • 10.2.1 Wellona Pharma Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Rifampicin
  • 10.2.4 Rifampicin Product Introduction
  • 10.2.5 Wellona Pharma Recent Development
• 10.3 AVANSCURE LIFESCIENCES
  • 10.3.1 AVANSCURE LIFESCIENCES Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Rifampicin
  • 10.3.4 Rifampicin Product Introduction
  • 10.3.5 AVANSCURE LIFESCIENCES Recent Development
• 10.4 Hebei Xingang Pharmaceutical
  • 10.4.1 Hebei Xingang Pharmaceutical Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Rifampicin
  • 10.4.4 Rifampicin Product Introduction
  • 10.4.5 Hebei Xingang Pharmaceutical Recent Development
• 10.5 Mercator Pharmaceutical Solutions
  • 10.5.1 Mercator Pharmaceutical Solutions Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Rifampicin
  • 10.5.4 Rifampicin Product Introduction
  • 10.5.5 Mercator Pharmaceutical Solutions Recent Development
• 10.6 ASIAN PHARMACY
  • 10.6.1 ASIAN PHARMACY Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Rifampicin
  • 10.6.4 Rifampicin Product Introduction
  • 10.6.5 ASIAN PHARMACY Recent Development
• 10.7 A. S. JOSHI & COMPANY
  • 10.7.1 A. S. JOSHI & COMPANY Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Rifampicin
  • 10.7.4 Rifampicin Product Introduction
  • 10.7.5 A. S. JOSHI & COMPANY Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Rifampicin Sales Channels
  • 11.2.2 Rifampicin Distributors
• 11.3 Rifampicin Customers

12 Market Forecast

• 12.1 Global Rifampicin Sales and Revenue Forecast 2019-2025
• 12.2 Global Rifampicin Sales Forecast by Type
• 12.3 Global Rifampicin Sales Forecast by Application
• 12.4 Rifampicin Forecast by Regions
  • 12.4.1 Global Rifampicin Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Rifampicin Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
In 2019, the market size of Rifampicin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Rifampicin.

This report studies the global market size of Rifampicin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Rifampicin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
A. S. JOSHI & COMPANY
...

Market Segment by Product Type
Oral
Intravenous Injection

Market Segment by Application
Tuberculosis
Leprosy
Legionnaire's Disease
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Rifampicin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Rifampicin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Rifampicin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025